CorMedix (CRMD) Net Cash Flow Growth (3y) (2015 - 2025)
CorMedix (CRMD) Net Cash Flow Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 32.17% |
| 10 | CorMedix | 4.94 Mn | -150.26 Mn | 107.31 Mn | 854.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 854.29% |
| Sep 30, 2025 | -168.61% |
| Jun 30, 2025 | 197.20% |
| Mar 31, 2025 | 73.62% |
| Dec 31, 2024 | 34.13% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | -29.07% |
| Mar 31, 2024 | -30.96% |
| Dec 31, 2023 | -48.63% |
| Sep 30, 2023 | 23.44% |
| Jun 30, 2023 | -48.99% |
| Mar 31, 2023 | -62.76% |
| Dec 31, 2022 | 69.18% |
| Sep 30, 2022 | -44.47% |
| Jun 30, 2022 | 43.56% |
| Mar 31, 2022 | -143.73% |
| Dec 31, 2021 | -46.78% |
| Sep 30, 2021 | -80.59% |
| Jun 30, 2021 | 3.31% |
| Mar 31, 2021 | 159.55% |